2021 Sep 7, 2021 Announcement of Collaborative Research Agreement for Creating a Solution to Predict Systemic Diseases from Eye Health Information Jul 20, 2021 Announcement of Commencement of Domestic Phase III Clinical Trial for Cytomegalovirus Endotheliitis Jun 30, 2021 We evaluated the performance of rapid test kits for coronavirus (SARS-CoV-2) antigens using laboratory samples. Jun 15, 2021 Initiation of Phase II Clinical Trial for Regenerative Medical Products Using Allogeneic Mesenchymal Stem Cells for Severe COVID-19 Pneumonia Patients Apr 14, 2021 Licensing Agreement with BioMimetics Sympathies for COVID-19 Treatment Candidate and Establishment of Research Organization 'RB⁺' to Uncover Novel Drug Targets from Regenerative Medicine Research Mar 23, 2021 Announcement Regarding Acquisition of Olympus RMS Corporation's Stock (Transfer Agreement) Mar 8, 2021 Announcement: Commencement of Domestic Phase II Clinical Trial of Janus Kinase Inhibitor "ROH-201"